{"id":1987,"date":"2025-06-26T10:21:29","date_gmt":"2025-06-26T08:21:29","guid":{"rendered":"https:\/\/studienportal-eierstockkrebs.de\/yumurtalik-kanseri-icin-en-oenemli-asco-sonuclari\/"},"modified":"2026-02-13T12:22:31","modified_gmt":"2026-02-13T11:22:31","slug":"yumurtalik-kanseri-icin-en-oenemli-asco-sonuclari","status":"publish","type":"post","link":"https:\/\/studienportal-eierstockkrebs.de\/tr\/yumurtalik-kanseri-icin-en-oenemli-asco-sonuclari\/","title":{"rendered":"Yumurtal\u0131k kanseri i\u00e7in en \u00f6nemli ASCO sonu\u00e7lar\u0131"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1987\" class=\"elementor elementor-1987 elementor-1148\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e438c86 e-flex e-con-boxed e-con e-parent\" data-id=\"e438c86\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2cf51b7 elementor-widget elementor-widget-heading\" data-id=\"2cf51b7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Yumurtal\u0131k kanseri i\u00e7in <strong>en \u00f6nemli ASCO sonu\u00e7lar\u0131 2025<\/strong><br> <\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fe93418 elementor-widget elementor-widget-image\" data-id=\"fe93418\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"625\" height=\"278\" src=\"https:\/\/studienportal-eierstockkrebs.de\/wp-content\/uploads\/PXL_20250625_133817582-900x400-1.jpg\" class=\"attachment-large size-large wp-image-1989\" alt=\"\" srcset=\"https:\/\/studienportal-eierstockkrebs.de\/wp-content\/uploads\/PXL_20250625_133817582-900x400-1.jpg 900w, https:\/\/studienportal-eierstockkrebs.de\/wp-content\/uploads\/PXL_20250625_133817582-900x400-1-300x133.jpg 300w, https:\/\/studienportal-eierstockkrebs.de\/wp-content\/uploads\/PXL_20250625_133817582-900x400-1-768x341.jpg 768w, https:\/\/studienportal-eierstockkrebs.de\/wp-content\/uploads\/PXL_20250625_133817582-900x400-1-624x277.jpg 624w\" sizes=\"(max-width: 625px) 100vw, 625px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-070f551 elementor-widget elementor-widget-text-editor\" data-id=\"070f551\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"114\" data-end=\"151\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">D\u00fcn, ASCO 2025&#8217;ten yumurtal\u0131k kanseri \u00fczerine \u00f6nemli \u00e7al\u0131\u015fmalar\u0131n sunuldu\u011fu 26. NOGGO Jinekolojik Onkoloji G\u00fcncellemesi ger\u00e7ekle\u015fti. Biz de oradayd\u0131k ve en \u00f6nemli bulgular\u0131 payla\u015fmak istiyoruz: <\/span><\/p>\n\n<h3>Birinci basamak tedavi &#8211; cerrahi<\/h3>\n<p data-start=\"195\" data-end=\"270\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"> <strong data-start=\"4\" data-end=\"20\">TRUST \u00e7al\u0131\u015fmas\u0131<\/strong>, <strong>primer cerrahinin<\/strong> (tan\u0131dan hemen sonra) <strong>ba\u015far\u0131s\u0131n\u0131n<\/strong> <strong>, cerrahi merkezin konumuna ve kalitesine<\/strong> \u00f6nemli \u00f6l\u00e7\u00fcde ba\u011fl\u0131 oldu\u011funu a\u00e7\u0131k\u00e7a g\u00f6stermi\u015ftir. Hemen cerrahi uygulanan hastalarda, aral\u0131kl\u0131 cerrahi (kemoterapi \u00f6n tedavisinden sonra cerrahi) uygulanan hastalara k\u0131yasla \u00f6nemli \u00f6l\u00e7\u00fcde daha uzun progresyonsuz sa\u011fkal\u0131m elde edilmi\u015ftir. Genel sa\u011fkal\u0131mda da say\u0131sal bir avantaj vard\u0131. Bunun i\u00e7in belirleyici fakt\u00f6r, ameliyat zaman\u0131ndan ba\u011f\u0131ms\u0131z olarak, sonunda <strong data-start=\"508\" data-end=\"542\">hi\u00e7bir t\u00fcm\u00f6r kal\u0131nt\u0131s\u0131n\u0131n (R0 sonucu) kalmamas\u0131yd\u0131<\/strong><\/span>. Dolay\u0131s\u0131yla birinci basamak tedavi i\u00e7in iyi bir merkezin se\u00e7ilmesi, hastal\u0131\u011f\u0131n sonraki seyri i\u00e7in belirleyicidir! <\/p>\n\n<h3>Birinci basamak tedavi &#8211; imm\u00fcnoterapi<\/h3>\n<p data-start=\"318\" data-end=\"355\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"7\" data-end=\"23\">FIRST \u00e7al\u0131\u015fmas\u0131<\/strong>, imm\u00fcnoterap\u00f6tik ajan <strong data-start=\"80\" data-end=\"95\">dostarlimab\u0131n<\/strong> birinci basamak kemoterapiye eklenmesinin bir avantaj sa\u011flay\u0131p sa\u011flamad\u0131\u011f\u0131n\u0131 ara\u015ft\u0131rm\u0131\u015ft\u0131r. Sonu\u00e7lar sadece \u0131l\u0131ml\u0131 bir etki g\u00f6stermi\u015ftir: progresyonsuz sa\u011fkal\u0131m (hastal\u0131\u011f\u0131n ilerlemedi\u011fi s\u00fcre) medyan 1,5 ay uzarken, genel sa\u011fkal\u0131m de\u011fi\u015fmemi\u015ftir. Ayr\u0131ca, \u00f6zellikle g\u00fc\u00e7l\u00fc fayda sa\u011flayan belirli bir hasta grubu tespit edilememi\u015ftir.  <\/span><\/p>\n\n<h3 data-start=\"357\" data-end=\"400\">N\u00fcks tedavisi &#8211; imm\u00fcnomod\u00fclasyon<\/h3>\n<p data-start=\"402\" data-end=\"477\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"> <strong data-start=\"4\" data-end=\"22\">ROSELLA \u00e7al\u0131\u015fmas\u0131<\/strong> platine diren\u00e7li yumurtal\u0131k kanseri olan hastalar i\u00e7in ger\u00e7ek bir ilerleme g\u00f6sterdi: <strong data-start=\"130\" data-end=\"146\">relacorilant<\/strong> ve kemoterap\u00f6tik ajan nab-paclitaxel kombinasyonu progresyonsuz sa\u011fkal\u0131m\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde uzatt\u0131 ve bir ara analiz <strong data-start=\"284\" data-end=\"337\">genel<\/strong> sa\u011fkal\u0131mda yakla\u015f\u0131k 4,5 ayl\u0131k <strong data-start=\"284\" data-end=\"337\">klinik olarak anlaml\u0131 bir fayda<\/strong> g\u00f6sterdi. Kombinasyon iyi tolere edilmi\u015f; <strong data-start=\"407\" data-end=\"441\">yeni bir g\u00fcvenlik sinyali<\/strong> ortaya \u00e7\u0131kmam\u0131\u015ft\u0131r<\/span>.<\/p>\n\n<h3 data-start=\"484\" data-end=\"529\">Klinikler ve hastalar i\u00e7in sonu\u00e7<\/h3>\n<p data-start=\"531\" data-end=\"950\">TRUST ve ROSELLA&#8217;dan gelen olumlu sinyallere ra\u011fmen, mevcut <strong data-start=\"599\" data-end=\"625\">k\u0131lavuzlar de\u011fi\u015fmeden kalm\u0131\u015ft\u0131r<\/strong>. Y\u00fcksek kaliteli cerrahinin \u00f6nemi TRUST \u00e7al\u0131\u015fmas\u0131yla daha da g\u00fc\u00e7lenirken, ROSELLA \u00e7al\u0131\u015fmas\u0131 relakorilant ve kemoterapi kombinasyonuyla n\u00fcks ortam\u0131nda somut ilerleme g\u00f6steren ilk \u00e7al\u0131\u015fmad\u0131r. Birinci basamakta imm\u00fcnolojik tedavinin eklenmesi \u015fimdiye kadar sadece s\u0131n\u0131rl\u0131 fayda g\u00f6stermi\u015ftir.  <\/p>\n<p data-start=\"952\" data-end=\"1160\">Sonu\u00e7lar heyecan verici bir g\u00f6r\u00fcn\u00fcm sunmakla birlikte, <strong data-start=\"1005\" data-end=\"1069\">mevcut k\u0131lavuzlar yerle\u015fik tedavileri \u00f6nermeye devam etmektedir<\/strong>. Yeni standartlar belirlemek i\u00e7in daha fazla analiz ve do\u011frulama \u00e7ok \u00f6nemli olacakt\u0131r. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Yumurtal\u0131k kanseri i\u00e7in en \u00f6nemli ASCO sonu\u00e7lar\u0131 2025 D\u00fcn, ASCO 2025&#8217;ten yumurtal\u0131k kanseri \u00fczerine \u00f6nemli \u00e7al\u0131\u015fmalar\u0131n sunuldu\u011fu 26. NOGGO Jinekolojik Onkoloji G\u00fcncellemesi ger\u00e7ekle\u015fti. Biz de oradayd\u0131k ve en \u00f6nemli bulgular\u0131 payla\u015fmak istiyoruz: Birinci basamak tedavi &#8211; cerrahi TRUST \u00e7al\u0131\u015fmas\u0131, primer cerrahinin (tan\u0131dan hemen sonra) ba\u015far\u0131s\u0131n\u0131n , cerrahi merkezin konumuna ve kalitesine \u00f6nemli \u00f6l\u00e7\u00fcde ba\u011fl\u0131 oldu\u011funu [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":1864,"comment_status":"closed","ping_status":"closed","sticky":true,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49,1],"tags":[],"class_list":["post-1987","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-haberler","category-nicht-kategorisiert"],"acf":[],"_links":{"self":[{"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/posts\/1987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/comments?post=1987"}],"version-history":[{"count":3,"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/posts\/1987\/revisions"}],"predecessor-version":[{"id":2008,"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/posts\/1987\/revisions\/2008"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/media\/1864"}],"wp:attachment":[{"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/media?parent=1987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/categories?post=1987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/studienportal-eierstockkrebs.de\/tr\/wp-json\/wp\/v2\/tags?post=1987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}